NCT05415254

Calcitriol Supplementation in COVID-19 Patients

A Randomized Open Label Study to Evaluate Efficacy of Calcitriol Supplementation in COVID-19 Patients With Vitamin D Deficiency

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 86 (estimated)
• Sponsor: RenJi Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized, open label study to evaluate the efficacy and safety of calcitriol supplementation in COVID-19 patients with vitamin D deficiency.

Detailed description

This is a randomized, open label study to evaluate the efficacy （clinical and laboratory change）and safety （serum calcium） of calcitriol supplementation in COVID-19 patients with vitamin D deficiency.

Conditions

• COVID-19
• Vitamin D Deficiency

Interventions

Type	Name	Description
DRUG	Calcitriol	Calcitriol supplementation orally

Timeline

• Start date: 2022-06-12
• Primary completion: 2022-08-19
• Completion: 2022-09-19
• First posted: 2022-06-13
• Last updated: 2022-06-13

Locations

1 site across 1 country: China